IMAP: Building the Next Phase Together

Over the past few months, we have been laying the foundations for what will become ASIF’s most ambitious and biggest programme to date, designed to deepen global understanding of both axial spondyloarthritis (axSpA) and psoriatic arthritis (PsA).

Since we first introduced IMAP (International Map of Axial Spondyloarthritis and Psoriatic Arthritis) in the last newsletter, ASIF has been working intensively with clinicians, patients and researchers to shape the framework and priorities of the study. A key milestone is the establishment of the IMAP Steering and Scientific Committees; these two groups that will guide the development and oversee the scientific rigour of the project. These committees bring together expert clinicians, researchers and, most importantly, people living with axSpA and PsA.

IMAP is using feedback from our members about what matters most: understanding delays to diagnosis, the impact of disease on quality of life, comorbidities, difficult‑to‑manage disease, and the psychological impact of living with these conditions.

Thank you to our members who have already indicated their readiness to be involved in IMAP. Your early support has been invaluable, and this project will be stronger because of your commitment.

As we move into the next phase of development, we invite all ASIF members who wish to contribute to IMAP to get in touch – your involvement will make a real difference both on a global and a local stage. IMAP will begin in Europe, and we look forward to launching the survey in the region at the end of the year.

If you would like to be part of IMAP, please contact Emily Kirkpatrick at emily.kirkpatrick@asif.info

IMAP: Building the Next Phase Together

Other NEWS

Watch On Demand: “Not Just Back Pain – Patient Experiences” Webinar in Spanish

Making Access Happen – Sandoz Global Access Forum 2026

Exploring the Value of Remission during the World Health Assembly